Go Pro

Health Catalyst (HCAT) 10K Form and Latest SEC Filings 2026

Health Catalyst logo
$2.24 +0.04 (+1.58%)
As of 12:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Health Catalyst SEC Filings & Recent Activity

Health Catalyst (NASDAQ:HCAT) has submitted 622+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Health Catalyst's financial statements. The most recent filing was a Form SCHEDULE 13G submitted on July 21, 2026.

Form 4
Health Catalyst, Inc. Reports Ownership Change on Jul. 20, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Health Catalyst Files Quarterly Report on May. 11, 2026

The 10-Q contains Health Catalyst's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Health Catalyst SEC Filing History

Browse Health Catalyst's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
07/21/2026 10:06 AM
Health Catalyst (1636422) Subject
Impax Asset Management Group plc (1749768) Filed by
Form SCHEDULE 13G
07/20/2026 4:18 PM
Health Catalyst (1636422) Issuer
Spencer Justin (1397180) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 4:19 PM
Health Catalyst (1636422) Issuer
Hoggard Green Jill (2046471) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2026 2:55 PM
Health Catalyst (1636422) Subject
Palogic Value Management, L.P. (1532943) Filed by
Form SCHEDULE 13D
06/15/2026 3:42 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 4:11 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2026 6:12 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D/A
06/04/2026 8:10 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2026 6:42 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:45 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:45 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:46 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 6:46 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2026 4:23 PM
Health Catalyst (1636422) Filer
Form DEFA14A
06/01/2026 4:35 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:36 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:36 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2026 4:37 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/11/2026 4:03 PM
Health Catalyst (1636422) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2026 4:16 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/04/2026 4:17 PM
Health Catalyst (1636422) Issuer
Nelson Steven H (1320490) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2026 4:25 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2026 3:33 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2026 4:19 PM
Health Catalyst (1636422) Filer
Form 10-K/A
04/27/2026 8:00 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2026 8:31 AM
Health Catalyst (1636422) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/13/2026 7:09 PM
First Light Asset Management, LLC (1600004) Filed by
Health Catalyst (1636422) Subject
Form SCHEDULE 13D/A
03/13/2026 7:13 AM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2026 4:10 PM
Health Catalyst (1636422) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2026 3:58 PM
Health Catalyst (1636422) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2026 7:39 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2026 5:47 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:47 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2026 5:48 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2026 6:14 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:15 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:15 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
03/02/2026 6:16 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:16 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/02/2026 6:17 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:35 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:37 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:28 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:29 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:30 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2026 7:31 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2026 6:03 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2026 12:04 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D/A
02/18/2026 7:59 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2026 3:15 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2026 7:39 AM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13D
01/14/2026 7:27 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13G/A
01/12/2026 3:26 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2025 4:25 PM
Health Catalyst (1636422) Subject
Stoney Lonesome HF LP (2014854) Filed by
Form SCHEDULE 13G
12/09/2025 5:37 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2025 5:37 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2025 3:24 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2025 3:08 PM
Health Catalyst (1636422) Subject
Larson-Green Julie (1796545) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2025 3:19 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:19 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:19 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:20 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:20 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:21 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:16 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2025 6:10 AM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2025 7:51 PM
Health Catalyst (1636422) Subject
Ross David Coy (2074748) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:43 PM
Health Catalyst (1636422) Subject
Landry Benjamin (1975281) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:44 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:44 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:46 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2025 7:47 PM
Health Catalyst (1636422) Subject
Llewelyn Linda (1780878) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 3:41 PM
First Light Asset Management, LLC (1600004) Filed by
Health Catalyst (1636422) Subject
Form SCHEDULE 13G/A
11/10/2025 3:17 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2025 3:23 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 3
Initial statement of beneficial ownership of securities  
09/26/2025 3:25 PM
Albert Benjamin (2086403) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025 4:20 PM
Health Catalyst (1636422) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2025 3:52 PM
Health Catalyst (1636422) Subject
Whetstone Capital Advisors, LLC (1607278) Filed by
Form SCHEDULE 13G
09/05/2025 3:53 PM
Gallagher Duncan (1780880) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2025 3:54 PM
Health Catalyst (1636422) Issuer
Larson-Green Julie (1796545) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:55 PM
Health Catalyst (1636422) Issuer
Ross David Coy (2074748) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
Landry Benjamin (1975281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
Llewelyn Linda (1780878) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Burton Daniel D. (1780980) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Health Catalyst (1636422) Issuer
LeSueur Daniel (2013388) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:33 PM
Alger Jason (1839111) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2025 5:34 PM
Freeman Kevin Lee (1945797) Reporting
Health Catalyst (1636422) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
1 Stock to Own by July 31st (Ad)

A scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-known name may be positioned to benefit while the Magnificent 7 stumbles. Smaller, overlooked stocks are showing growing potential to challenge AI's biggest players. One specific ticker stands out heading into that date.tc pixel

Get the name and ticker of this stock on your radar now
(Data available from 1/1/2016 forward)

Health Catalyst SEC Filings - Frequently Asked Questions

Health Catalyst (HCAT) has submitted 622+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Health Catalyst's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Health Catalyst's financial statements page.

The most recent filing was a Form SCHEDULE 13G submitted on July 21, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:HCAT) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners